REPORT ID 6506

United States Anticoagulants Drug Market Report 2017

Publish Date
26-Dec-17
Pages
109
Format
Electronic (PDF)

In this report, the United States Anticoagulants Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Anticoagulants Drug in these regions, from 2012 to 2022 (forecast).

United States Anticoagulants Drug market competition by top manufacturers/players, with Anticoagulants Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    C. H. Boehringer Sohn (Germany)
    Bristol-Myers Squibb (US)
    Johnson & Johnson (US)
    Pfizer (US)
    Daiichi Sankyo (Japan)
    Portola Pharmaceuticals (US)
    Roche (Switzerland)
    Abbott (US)
    Siemens (Germany)
    Alere (US)
    CoaguSense (US)

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Novel Oral Anticoagulants (NOACs)
    Warfarin (VKA)
    Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospital
    Clinic
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Anticoagulants Drug Market Report 2017
1 Anticoagulants Drug Overview
    1.1 Product Overview and Scope of Anticoagulants Drug
    1.2 Classification of Anticoagulants Drug by Product Category
        1.2.1 United States Anticoagulants Drug Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Anticoagulants Drug Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Novel Oral Anticoagulants (NOACs)
        1.2.4 Warfarin (VKA)
        1.2.5 Others
    1.3 United States Anticoagulants Drug Market by Application/End Users
        1.3.1 United States Anticoagulants Drug Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Others
    1.4 United States Anticoagulants Drug Market by Region
        1.4.1 United States Anticoagulants Drug Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Anticoagulants Drug Status and Prospect (2012-2022)
        1.4.3 Southwest Anticoagulants Drug Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Anticoagulants Drug Status and Prospect (2012-2022)
        1.4.5 New England Anticoagulants Drug Status and Prospect (2012-2022)
        1.4.6 The South Anticoagulants Drug Status and Prospect (2012-2022)
        1.4.7 The Midwest Anticoagulants Drug Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Anticoagulants Drug (2012-2022)
        1.5.1 United States Anticoagulants Drug Sales and Growth Rate (2012-2022)
        1.5.2 United States Anticoagulants Drug Revenue and Growth Rate (2012-2022)

2 United States Anticoagulants Drug Market Competition by Players/Suppliers
    2.1 United States Anticoagulants Drug Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Anticoagulants Drug Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Anticoagulants Drug Average Price by Players/Suppliers (2012-2017)
    2.4 United States Anticoagulants Drug Market Competitive Situation and Trends
        2.4.1 United States Anticoagulants Drug Market Concentration Rate
        2.4.2 United States Anticoagulants Drug Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Anticoagulants Drug Manufacturing Base Distribution, Sales Area, Product Type

3 United States Anticoagulants Drug Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Anticoagulants Drug Sales and Market Share by Region (2012-2017)
    3.2 United States Anticoagulants Drug Revenue and Market Share by Region (2012-2017)
    3.3 United States Anticoagulants Drug Price by Region (2012-2017)

4 United States Anticoagulants Drug Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Anticoagulants Drug Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Anticoagulants Drug Revenue and Market Share by Type (2012-2017)
    4.3 United States Anticoagulants Drug Price by Type (2012-2017)
    4.4 United States Anticoagulants Drug Sales Growth Rate by Type (2012-2017)

5 United States Anticoagulants Drug Sales (Volume) by Application (2012-2017)
    5.1 United States Anticoagulants Drug Sales and Market Share by Application (2012-2017)
    5.2 United States Anticoagulants Drug Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Anticoagulants Drug Players/Suppliers Profiles and Sales Data
    6.1 C. H. Boehringer Sohn (Germany)
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Anticoagulants Drug Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 C. H. Boehringer Sohn (Germany) Anticoagulants Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Bristol-Myers Squibb (US)
        6.2.2 Anticoagulants Drug Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Bristol-Myers Squibb (US) Anticoagulants Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Johnson & Johnson (US)
        6.3.2 Anticoagulants Drug Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Johnson & Johnson (US) Anticoagulants Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Pfizer (US)
        6.4.2 Anticoagulants Drug Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Pfizer (US) Anticoagulants Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Daiichi Sankyo (Japan)
        6.5.2 Anticoagulants Drug Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Daiichi Sankyo (Japan) Anticoagulants Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Portola Pharmaceuticals (US)
        6.6.2 Anticoagulants Drug Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Portola Pharmaceuticals (US) Anticoagulants Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Roche (Switzerland)
        6.7.2 Anticoagulants Drug Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Roche (Switzerland) Anticoagulants Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Abbott (US)
        6.8.2 Anticoagulants Drug Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Abbott (US) Anticoagulants Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Siemens (Germany)
        6.9.2 Anticoagulants Drug Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Siemens (Germany) Anticoagulants Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Alere (US)
        6.10.2 Anticoagulants Drug Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Alere (US) Anticoagulants Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 CoaguSense (US)

7 Anticoagulants Drug Manufacturing Cost Analysis
    7.1 Anticoagulants Drug Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Anticoagulants Drug

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Anticoagulants Drug Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Anticoagulants Drug Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Anticoagulants Drug Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Anticoagulants Drug Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Anticoagulants Drug Sales Volume Forecast by Type (2017-2022)
    11.3 United States Anticoagulants Drug Sales Volume Forecast by Application (2017-2022)
    11.4 United States Anticoagulants Drug Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer